Healthcare expenditures associated with cardiovascular, chronic kidney, and diabetic conditions, 2021–2023
Devki Patel, Holly J Kramer, Abigail Silva, Fares Qeadan, Talar W Markossian · 2026
Read Healthcare expenditures associated with cardiovascular, chronic kidney, and diabetic conditions, 2021–2023 by Devki Patel, Holly J Kramer, Abigail Silva, Fares Qeadan, Talar W Markossian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13480066.txt.
Description
Devki Patel and colleagues report a 2026 study of health care costs tied to diabetes, heart disease, and chronic kidney disease in United States adults. The team pooled national survey data from 2021 through 2023. Groups held adults with diabetes alone, heart disease alone, kidney disease alone, or at least two of the three, and models weighed age, sex, and other social factors.
Adults with two or more of the conditions carried the highest yearly costs, with total spending near double that of diabetes alone. Their out-of-pocket drug costs also topped the list, while the kidney-only group showed the lowest drug outlay, though that group held just 44 people and its figures carry wide doubt. Total spending was lowest for diabetes alone. The pattern argues for focused financial and clinical help for people juggling several long-term conditions at once.
Catalog record
| CREATOR | Devki Patel, Holly J Kramer, Abigail Silva, Fares Qeadan, Talar W Markossian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36026 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |